Neuren Pharmaceuticals | NEU - Current Assets

Stock Price
12.03
Daily Change
-0.57 -4.52%
Monthly
-30.66%
Yearly
-10.16%
Q1 Forecast
12.80

Neuren Pharmaceuticals reported AUD320.25M in Current Assets for its fiscal semester ending in June of 2025.





Current Assets Change Date
Akebia Therapeutics USD 258.34M 23.68M Sep/2025
Alaunos Therapeutics USD 2.68M 1.05M Sep/2025
Avita Medical AUD 36.25M 20.75M Jun/2025
Clinuvel Pharmaceuticals AUD 222.06M 20.56M Jun/2024
Dianthus Therapeutics USD 413.82M 150.22M Sep/2025
Genetic Signatures AUD 47.98M 3.59M Jun/2025
Ionis Pharmaceuticals USD 2.52B 58.16M Sep/2025
Medical Developments International AUD 35.54M 2.13M Jun/2025
Neuren Pharmaceuticals AUD 320.25M 79.08M Jun/2025
Organon & Co USD 4.7B 82M Sep/2025
Paradigm Biopharmaceuticals AUD 24.13M 8.16M Jun/2025
PYC Therapeutics AUD 177.53M 115.4M Jun/2025
Starpharma Holdings AUD 22.56M 3.69M Jun/2025
Tectonic Therapeutic USD 273.24M 17.61M Sep/2025
Telix Pharmaceuticals AUD 330.28M 67.73M Dec/2025
Viatris USD 9.95B 176.8M Sep/2025
Xeris Pharmaceuticals USD 224.02M 38.44M Sep/2025